The bankruptcy reorganization of Kangmei Pharmaceutical Co.Ltd(600518) (600518) was settled with the acquisition of Shennong of Guangzhou Pharmaceutical Department and the settlement of all non operating funds of related parties. Kangmei Pharmaceutical Co.Ltd(600518) shares also rose 18.73% in seven trading days to welcome new owners.
It is reported that the “new owner” Shennong has been fully involved in the production and operation of Kangmei Pharmaceutical Co.Ltd(600518) . At present, the general manager of Kangmei Pharmaceutical Co.Ltd(600518) and many deputy general managers are from Guangzhou Pharmaceutical Group, and there are about 100 Guangzhou Pharmaceutical teams settled in Kangmei.
On January 4, Guangzhou Pharmaceutical Group rushed to Xi’an with 5 million yuan of epidemic prevention materials raised by Kangmei pharmaceutical, which also marked the beginning of concerted action between the two enterprises.
On January 7, Kangmei Pharmaceutical Co.Ltd(600518) issued several announcements on the nomination of candidates for the board of directors and the board of supervisors, which means that the board of directors and the board of supervisors of the company will complete the replacement soon. The change of Dong Jiangao’s team also means that Kangmei Pharmaceutical Co.Ltd(600518) has taken a key step in rebirth.
Kangmei Pharmaceutical Co.Ltd(600518) the board of directors adopted a resolution to nominate Lai Zhijian, MI Qi, Liu Guowei, Liang Jun, Yang Weirong and Fang miaoshuang as candidates for non independent directors of the ninth board of directors of the company.
At the same time, Kangmei Pharmaceutical Co.Ltd(600518) ‘s new list of independent directors and members of the board of supervisors has been basically determined: Luo Tao, Lai Xiaoping and Zeng Qing have been nominated as candidates for independent directors of the board of directors; Nominate Gao Yanzhu and Wang Tong as candidates for non employee representative supervisors of the board of supervisors; Huang Longtao is recommended as the employee supervisor of the board of supervisors.
from the candidate’s resume, among the new directors of Kangmei Pharmaceutical Co.Ltd(600518) , many non independent directors are from Guangzhou Pharmaceutical Group. The remaining directors are also accredited by Shennong’s shareholders Guangdong Yuecai and Jinye development.
Resume of non independent director candidates:
1. Lai Zhijian was born in March 1969. He is now the deputy director of quality, director of technology and quality department and director of work safety development department of Guangzhou Pharmaceutical Group Co., Ltd.
2. Mickey was born in December 1962. He is currently secretary and director of the Discipline Inspection Commission of Guangzhou Pharmaceutical Co., Ltd.
3. Liu Guowei was born in October 1973. From March 2016 to October 2020, he successively served as member of the Party committee, director and general manager of Guangzhou Caizhilin Pharmaceutical Co., Ltd., executive director and general manager of Guangzhou Shennong’s traditional Chinese Medicine Development Co., Ltd. Served as Kangmei Pharmaceutical Co.Ltd(600518) director and general manager since October 2020.
4. Liang Jun was born in February 1984. He is currently the director and deputy general manager of Guangdong Yuecai Fund Management Co., Ltd., Guangdong Yuecai Equity Investment Co., Ltd. and Guangdong Yuecai Venture Capital Co., Ltd.
5. Yang Weirong was born in July 1975. He is currently the general manager of Guangdong HENGJIAN Asset Management Co., Ltd. and the chairman of Guangdong state owned enterprise restructuring and Development Fund Management Co., Ltd.
6. Ms. Fang miaoshuang, April 1977. He is currently the deputy general manager of Jieyang golden leaf development company, member of the Party committee and deputy general manager of Jieyang Investment Holding Group Co., Ltd., and director of Guangdong Jiedong agricultural commercial bank.
Resume of independent director candidates:
1. Luo Tao was born in 1973. He is now the Director / deputy chief accountant of Guangzhou Huasui certified public accountants Co., Ltd., the executive director of Guangzhou Institute of certified public accountants, the director of Guangdong Institute of certified public accountants, the off campus tutor of Accounting Master students of Jinan University, Guangdong University of technology, Guangdong University of Finance and economics and Guangzhou University, Cedar Development Co.Ltd(002485) independent director.
2. Lai Xiaoping was born in October 1960. Since August 1985, he has successively served as lecturer in the teaching and Research Department of traditional Chinese medicine identification of Guangzhou University of traditional Chinese medicine, Secretary of the Party branch and director of the scientific research department of the Institute of traditional Chinese medicine development, director of the new drug development and research center and President of the College of traditional Chinese medicine (new drug development and Research Center). From October 2020, Kangmei Pharmaceutical Co.Ltd(600518) independent director.
3. Zeng Qing was born in May 1964. He has successively engaged in technology R & D, R & D management and enterprise management in the R & D center of Johnson & Johnson pharmaceutical company, Schering plough pharmaceutical company, Novum pharmaceutical research services, atvis Foshan Pharmaceutical Co., Ltd., Guangzhou Haozhi Biotechnology Co., Ltd. and Guangzhou kangliming Biotechnology Co., Ltd.
(source: e company)
